Peter Sordillo
Direttore Tecnico/Scientifico/R&S presso SignPath Pharma, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Kai P. Larson | M | 60 |
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 9 anni |
| Jack Levine | M | 73 |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 14 anni |
| Arthur P. Bollon | M | 81 |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 16 anni |
| Kristján Tómas Ragnarsson | M | 80 |
Icahn School of Medicine at Mount Sinai
| - |
| Tom Strauss | M | 82 |
Icahn School of Medicine at Mount Sinai
| - |
| George M. Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| John R. Tomasula | M | 69 |
Icahn School of Medicine at Mount Sinai
| 22 anni |
| Ross L. Cagan | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Barbara Paris | M | 72 |
Icahn School of Medicine at Mount Sinai
| 21 anni |
| Hina Waheed Chaudhry | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Scott L. Friedman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Robert J. Desnick | M | - |
Icahn School of Medicine at Mount Sinai
| 15 anni |
| Kevin David Costa | M | - |
Icahn School of Medicine at Mount Sinai
| 15 anni |
| Jeffrey Vacirca | M | 55 |
Icahn School of Medicine at Mount Sinai
| 6 anni |
| Gary Goldenberg | M | 47 |
Icahn School of Medicine at Mount Sinai
| 15 anni |
| Sundar Jagannath | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Joshua Brody | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Stephen Dahmer | M | 49 |
Icahn School of Medicine at Mount Sinai
| 9 anni |
| Stephen Spencer | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 7 anni |
| Eric Schadt | M | 59 |
Icahn School of Medicine at Mount Sinai
| 13 anni |
| Gregory M. Heard | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 5 anni |
| Edward Lung | M | - |
Icahn School of Medicine at Mount Sinai
| 21 anni |
| Jeffrey S. Starman | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 3 anni |
| Bradley J. Hayosh | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 3 anni |
| Lisa Edelmann | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Lawrence Tanenbaum | M | 66 |
Icahn School of Medicine at Mount Sinai
| 16 anni |
| Judy Cho | F | - |
Icahn School of Medicine at Mount Sinai
| - |
| Elissa Levin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
| Alain Carpentier | M | 91 |
Icahn School of Medicine at Mount Sinai
| - |
| Andrew Russell | M | 52 |
Icahn School of Medicine at Mount Sinai
| 9 anni |
| Michael R. Hausman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| John H. Morrison | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Steven J. Burakoff | M | 81 |
Icahn School of Medicine at Mount Sinai
| - |
| Melvin M. van Woert | M | 93 |
Icahn School of Medicine at Mount Sinai
| 46 anni |
| Samuel Marcus Waxman | M | - |
Icahn School of Medicine at Mount Sinai
| 41 anni |
| Lester B. Salans | M | 88 |
Icahn School of Medicine at Mount Sinai
| - |
| Ariel Recanati | M | 60 |
Icahn School of Medicine at Mount Sinai
| - |
| Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 anni |
| Michael Donovan | M | 70 |
Icahn School of Medicine at Mount Sinai
| 13 anni |
| Stephen B. Thacker | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Holly G. Atkinson | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Francesco Ramirez | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Carlos Cordón-Cardó | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Dennis Charney | M | 72 |
Icahn School of Medicine at Mount Sinai
| 20 anni |
| Steve Hochberg | M | 62 |
Icahn School of Medicine at Mount Sinai
| - |
| Janice L. Gabrilove | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Arthur A. Klein | M | 76 |
Icahn School of Medicine at Mount Sinai
| - |
| E. Premkumar Reddy | M | 80 |
Icahn School of Medicine at Mount Sinai
| 14 anni |
| Hendrick Coenraad Hemker | M | 90 |
Icahn School of Medicine at Mount Sinai
| - |
| Robert Seguso | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 7 anni |
| Angela Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Jay Schechtman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Preeti Parikh | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Andrew M. Saul | M | 77 |
Icahn School of Medicine at Mount Sinai
| - |
| Lisa Satlin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 55 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Peter Sordillo
- Contatti personali
